Darenzepine
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Product Specifications
CAS Number
[84629-61-8]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Darenzepine.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=CC=C1/2)C3=CC=CC=C3C2=C/C(N4CCN(C)CC4)=O
Molecular Formula
C21H21N3O2
Molecular Weight
347.41
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
035027-FITC 200 µL
ELAVL2, ID (ELAVL2, HUB, ELAV-like protein 2, ELAV-like neuronal protein 1, Hu-antigen B, Nervous system-specific RNA-binding protein Hel-N1) (FITC) discontinued
Ask
View Details